Dr. Reddy's launches India's only immuno-onco drug for a form of neck and head cancer - CNBC-TV18

Dr. Reddy's Laboratories Ltd., along with its subsidiaries, announced the launch of Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.